[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100562933":3},{"organization":4,"outcomesModule":7,"designInfo":27,"detailedDescription":33,"studyPopulation":26,"armGroups":34,"interventions":47,"overallOfficials":55,"centralContacts":60,"locations":68,"responsibleParty":85,"collaborators":26,"id":87,"slug":26,"hasResults":88,"nctId":89,"briefTitle":90,"officialTitle":91,"acronym":26,"eligibilityCriteria":92,"healthyVolunteers":93,"sex":94,"minAge":95,"maxAge":96,"enrollmentInfo":97,"targetDuration":26,"studyType":100,"phases":101,"briefSummary":103,"conditions":104,"keywords":26,"overallStatus":70,"whyStopped":26,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"Amorepacific Corporation","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":26},[9],{"measure":10,"description":11,"timeFrame":12},"Change of body fat by DEXA","Measurement was made by using dual-energy X-ray absorption(DEXA)","Baseline, Week 12",[14,17,20,23],{"measure":15,"description":16,"timeFrame":12},"Changes of total abdominal fat area, visceral fat area and subcutaneous fat area","Measurement of the target area is made using computed tomography",{"measure":18,"description":19,"timeFrame":12},"Changes of indicator of lipid metabolism","indicator of lipid metabolism (i.e., TC, TG, HDL, LDL)",{"measure":21,"description":22,"timeFrame":12},"Changes of waist circumference","Measurement of waist circumfernece was performed in accordance with WHO guideline",{"measure":24,"description":25,"timeFrame":12},"Changes of blood biomarker","adiponectin, etc.",null,{"allocation":28,"interventionModel":29,"interventionModelDescription":26,"primaryPurpose":30,"observationalModel":26,"timePerspective":26,"maskingInfo":31},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":32,"maskingDescription":26,"whoMasked":26},"NONE","This study is a 12-week, randomized, double-blind, placebo-controlled clinical trial. 100 subjects were ranromly assigned to heat-treated green tea extract(HTGT) group and placebo group. The changes in the efficacy endpoint were evaluated after treatment of 2 capsules of HTGT once daiy for 12 weeks.",[35,41],{"label":36,"type":37,"description":38,"interventionNames":39},"HTGT compound","EXPERIMENTAL","* Dietary supplement: HTGT compound\n\n  * oral administration of HTGT compound once daily, 2 capsules per day.\n* Dietary supplement; Placebo\n\n  * oral administration of placebo once daily, 2 canpules per day",[40],"Dietary Supplement: HTGT compound",{"label":42,"type":43,"description":44,"interventionNames":45},"Placebo","PLACEBO_COMPARATOR","Once daily, 2 capsules per day",[46],"Dietary Supplement: Placebo",[48,52],{"type":49,"name":36,"description":50,"armGroupLabels":51,"otherNames":26},"DIETARY_SUPPLEMENT","oral administration of HTGT compound once daily",[36],{"type":49,"name":42,"description":53,"armGroupLabels":54,"otherNames":26},"Oral administration of placebo once daily",[42],[56],{"name":57,"affiliation":58,"role":59},"Sang-Wook Song, M.D.\u002FPh.D","Catholic University St. Vincent Hospital","PRINCIPAL_INVESTIGATOR",[61,66],{"name":62,"role":63,"phone":64,"phoneExt":26,"email":65},"Jonghee Sohn","CONTACT","800-555-5555","sohnjh@amorepacific.com",{"name":67,"role":63,"phone":26,"phoneExt":26,"email":26},"HyunJin Nam, Ph.D.",[69],{"facility":58,"status":70,"city":71,"state":72,"zip":26,"country":73,"countryCode":26,"cosmosGeoPoint":74,"geoPoint":79,"contacts":80},"RECRUITING","Suwon","Gyeonggi-do","South Korea",{"type":75,"coordinates":76},"Point",[77,78],127.00889,37.29111,{"lat":78,"lon":77},[81],{"name":82,"role":63,"phone":83,"phoneExt":26,"email":84},"Sang-Wook Song, M.D.\u002FPh.D.","82-31-881-8859","fmssw@catholic.ac.kr",{"type":86,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100562933",false,"NCT06609603","Clinical Study to Evaluate the Body Fat Reducing Effects of Heat-Treated Green Tea Extract Complex","A Randomized, Double-blind, Placebo-controlled, Parallel-design Clinical Study to Evaluate the Body Fat Reducing Effect of Heat-Treated Green Tea Extract Complex","* lt;Inclusion Criteria\\>\n\n  * Males and females aged between 19 \\~ 64 years\n  * BMI 25.0 \\~ 34.9 kg\u002Fm\\^2\n  * Waist circumferebce: 90cm or more for men, 85cm or more for women\n  * Subjects who have fully understand the information provided about the study and voluntarily decided to participate\n* lt;Exclusion Criteria\\>\n\n  * Participants whose weight changed by more than 10% within the 3 months prior to visit 1\n  * Individuals participated in a commercial weight loss program within 3 months prior to Visit 1\n  * Participants who have undergone surgical procedures within 3 years\n  * Participants who have taken obesity treatment medications within the last 3 months\n  * Individuals who have taken medications affecting weight or dietary supplements for weight control within the last month\n  * Subjects with uncontrolled hypertension\n  * Subjects diagnosed with diabetes\n  * TSH \\<0.1 uIU\u002Fml or \\>10 uIU\u002Fml\n  * Creatinine \\>1.5mg\u002FdL\n  * AST or ALT \\> three times the upper normal limit",true,"ALL","19 Years","64 Years",{"count":98,"type":99},100,"ESTIMATED","INTERVENTIONAL",[102],"NA","This clinical study was designed to evaluate the efficacy and safety of body fat reduction in obese adults by treatment of heat-treated green tea extract complex",[105],"Body Fat","2024-09-19",{"date":108,"type":109},"2024-09-24","ACTUAL",{"date":111,"type":109},"2023-11-17",{"date":113,"type":99},"2025-06-30",{"name":5,"class":6},1]